Institutions / Deerfield Management Company, L.P. / Activity
Activity — Deerfield Management Company, L.P.
112 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2026 as of | Exit | WOOF Petco Health & Wellness Company, Inc. Common Stock | $-2.63M | -936K -100.00% | 0 | low |
| Q1 2026 as of | Exit | KIDS Orthopediatrics Corp Common Stock | $-2.56M | -144K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Cigna Group Common stock | $-2.53M | -9K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Trupanion, Inc. Common stock | $-2.48M | -66K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Resmed Inc Common stock | $-2.43M | -10K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Boston Scientific Corp Common stock | $-2.38M | -25K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Davita Inc. Common stock | $-2.38M | -21K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Doximity, Inc. Common stock | $-2.30M | -52K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Dexcom Inc Common stock | $-2.19M | -33K -100.00% | 0 | low |
| Q1 2026 as of | Exit | iRhythm Holdings, Inc. Common stock | $-2.15M | -12K -100.00% | 0 | low |
| Q1 2026 as of | Exit | CONMED Corp Common stock | $-2.13M | -53K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Masimo Corporation Common stock | $-2.10M | -16K -100.00% | 0 | low |
| Q1 2026 as of | Exit | LeMaitre Vascular, Inc. Common stock | $-2.09M | -26K -100.00% | 0 | low |
| Q1 2026 as of | Exit | 10x Genomics, Inc. Common stock | $-2.06M | -127K -100.00% | 0 | low |
| Q1 2026 as of | Exit | AtriCure Inc Common stock | $-2.06M | -52K -100.00% | 0 | low |
| Q1 2026 as of | Trim | Embecta Corp. Common stock | $-1.92M | -217K -7.89% | 2,534,961 0.33% of portfolio | low |
| Q1 2026 as of | Exit | Avanos Medical, Inc. Common stock | $-1.88M | -167K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Corvel Corp Common stock | $-1.87M | -28K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Cardinal Health Inc Common stock | $-1.85M | -9K -100.00% | 0 | low |
| Q1 2026 as of | Exit | GoodRx Holdings, Inc. Common stock | $-1.79M | -660K -100.00% | 0 | low |
| Q1 2026 as of | Trim | Envista Holdings Corp Common stock | $-1.79M | -70K -3.09% | 2,210,100 0.84% of portfolio | low |
| Q1 2026 as of | Exit | Surgery Partners, Inc. Common stock | $-1.74M | -113K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Align Technology, Inc. Common stock | $-1.72M | -11K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Addus HomeCare Corp Common stock | $-1.70M | -16K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Merit Medical Systems Inc Common stock | $-1.66M | -19K -100.00% | 0 | low |
| Q1 2026 as of | Exit | National HealthCare Corp Common stock | $-1.66M | -12K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Encompass Health Corp Common stock | $-1.62M | -15K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Varex Imaging Corp Common stock | $-1.53M | -132K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Healthequity, Inc. Common stock | $-1.49M | -16K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Abbott Laboratories Common stock | $-1.43M | -11K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Maximus Inc Common stock | $-1.43M | -17K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Stryker Corp Common stock | $-1.25M | -4K -100.00% | 0 | low |
| Q1 2026 as of | Exit | ATEC Alphatec Holdings, Inc. Common Stock | $-1.21M | -57K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Staar Surgical Co Common stock | $-1.20M | -52K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Ufp Technologies Inc Common stock | $-1.13M | -5K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Kenvue Inc. Common stock | $-1.13M | -65K -100.00% | 0 | low |
| Q1 2026 as of | Exit | MDXG Mimedx Group, Inc. Common Stock | $-1.09M | -160K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Integer Holdings Corp Common stock | $-1.05M | -13K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Revvity, Inc. Common stock | $-998.8K | -10K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Azenta Inc Common stock | $-859.3K | -26K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Arvinas, Inc. Common stock | $-807.2K | -68K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Zoetis Inc. Common stock | $-716.9K | -6K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Cooper Companies, Inc. Common stock | $-638.1K | -8K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Schrodinger, Inc. Common stock | $-607.7K | -34K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Tandem Diabetes Care Inc Common stock | $-573.5K | -26K -100.00% | 0 | low |
| Q1 2026 as of | Exit | RxSight, Inc. Common stock | $-544.5K | -52K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Integra Lifesciences Holdings Corp Common stock | $-487.0K | -39K -100.00% | 0 | low |
| Q1 2026 as of | Exit | AbbVie Inc. Common stock | $-460.2K | -2K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Harrow, Inc. Common stock | $-426.0K | -9K -100.00% | 0 | low |
| Q1 2026 as of | Exit | Xeris Biopharma Holdings, Inc. Common stock | $-410.0K | -52K -100.00% | 0 | low |